===
Guerbet
Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term
ambitions.
11-March-2024 / 08:00 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.  
Guerbet strengthens its Executive Committee        with two new appointments to consolidate                 its medium 

and long-term ambitions
. Christine Allard, SVP Public Affairs and Corporate Communications
. Eva Ohlsson, SVP Human Resources
Villepinte, 11 march 2024: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical
imaging, announces the strengthening of its management team with two appointments. Christine Allard and Eva Ohlsson
have joined the Group as senior Vice-President Public Affairs and Corporate Communications, and Senior Vice President
Human Resources respectively. Reporting directly to David Hale, Chief Executive Officer, they will both become members
of Guerbet's Executive Committee.
Christine Allard brings over 25 years of experience across sales, marketing, communications, corporate social
responsibility, and public affairs. She has held a variety of different roles at both the regional and group level at
BSN-Danone, Pechiney-Alcan, and most recently with the group Sanef-Abertis where she was Director of Communications and
Public Affairs. Christine Allard will leverage her expertise in corportae and digital communications, corporate social
responsibility programs as well as her established relationships with key government institutions to contribute to
Guerbet's strategic development. She is also President of the Chamber of Commerce of Spain in France (COCEF) and
received the distinction of "Chevalier dans l'Ordre de la Légion d'Honneur" in 2009.


Eva Ohlsson brings over 20 years of human resources (HR) experience with specific expertise in recruiting, developing
and managing talent in the healthcare sector. She has held a variety of different HR roles at both the regional and
global level, has been HR business partner for commercial, R&D and Product Development organizations. During the past
five years, Eva Ohlsson was the Group HR Director for Stago, a global player in the In-Vitro Diagnosis (IVD) industry,
wholly dedicated to the exploration of hemostasis and thrombosis. She played a full part in the development of this
french based family-owned healthcare group, which is characterised both by numerous sales affiliates around the world
and a large industrial network split between France, United States and China. Eva was also in charge of co-leading the
Corporate Sustainability Initiative for Stago.

Guerbet's Executive Committee now has 10 members: . David Hale, Chief Executive Officer . Christine Allard, SVP Public Affairs and Corporate Communications . Charlotte Bamière, General Counsel & SVP Compliance . Raoul Bernhardt, SVP Industrial Operations, EHS and Procurement . Philippe Bourrinet, SVP Development, Medical & Regulatory Affairs and Group Responsible Pharmacist . Valérie Brissart, SVP Marketing - Diagnostic Imaging . Jérôme Estampes, Chief Financial Officer and SVP IT and Business Development & Licensing . François Nicolas, SVP Research, Development, Innovation and AI . Eva Ohlsson, SVP Human Resources . Dan Raffi, SVP Commercial Operations Upcoming event: Publication of 2023 annual revenue 20 march 2024 after trading About Guerbet At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a world leader in medical imaging, offering a complete range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. Pioneers in contrast media for 95 years, with more than 2,830 employees worldwide, we are constantly innovating and devote 8% to 10% of our revenue to research and development in five centres in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B-mid caps) and generated EUR753 million in revenue in 2022. For more information, please visit www.guerbet.com. Contacts: Guerbet Jérôme Estampes, Chief Financial Officer +33.1.45.91.50.00 / jerome.estampes@guerbet.com Christine Allard, Public Affairs and Corporate Communications Director +33.6.30.11.57.82 / christine.allard@guerbet.com Seitosei.Actifin Marianne Py, Financial Communications + 33.1.56.88.11.25 / mpy@actifin.fr Jennifer Jullia, Press +33.1.56.88.11.19 / jjullia@actifin.fr
===
-----------------------------------------------------------------------------------------------------------------------

Regulatory filing PDF file File: GUERBET_nominations_11032024ukVdef

===

Language:        English 
Company:         Guerbet 

Zone Paris Nord II 15 Rue des Vanesses
93420 Villepinte
France

Internet:        https://www.guerbet.com/investors 
ISIN:            FR0000032526 

Euronext Ticker: GBT

AMF Category:    Inside information / Other releases 
EQS News ID:     1855041 

End of Announcement EQS News Service
===
1855041 11-March-2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1855041&application_name=news

END) Dow Jones Newswires

March 11, 2024 03:00 ET (07:00 GMT)